Hightower can contribute to technical due diligence associated with mergers, acquisitions, and product licensing.
​
Hightower can help you select drug delivery technology for your new chemical entity.
​
Hightower can lead the selection and management of contract research organizations.
​
Hightower can direct the development and validation of analytical methods applied to drug substances, drug products, and biological samples.
​
Hightower can direct and interpret the pre-formulation characterization of your new chemical entity.
​
Hightower can direct the work necessary to remediate CMC deficiencies and can craft descriptive FDA responses.
​
​
​
Dr. Bannister can serve as a consulting or testifying expert on drug-analysis, drug-development, and drug-manufacturing issues for counsel in civil and criminal cases.
​
​
​